Clinical Trial Update: Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin Resistance [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update evaluating the combination of metformin, pegylated interferon alfa, and ribavirin for chronic hepatitis C with insulin resistanc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Insulin Resistance

Drugs mentioned

• Pegylated interferon alpha (Pegylated interferon alfa)
• Ribavirin (ribavirin)
• metformin (metformin)

Snippet

Sponsor: Kaohsiung Veterans General Hospital. | Conditions: Chronic Hepatitis c, Insulin Resistance | Phase 2, Phase 3 | Status: UNKNOWN